Avohoidon Tutkimussäätiö (investor - Others)

See something wrong or missing? Let us know
Offices:Espoo

Avohoidon Tutkimussäätiö is a foundation acting as an independent charitable fund that makes direct investments in companies from healthcare, pharma and biotech sectors.

Average round investment:766.163k USD
Average number per year:2.0
Distribution: 2021 (2)
Portfolio companies: Finland CurifyLabsFinland StemSight
Mostly invests in: Finland Finland (2) Manufacturing (2)

2 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Avohoidon Tutkimussäätiö

Name Criteria
Finland Sauli Törmälä
79%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 1.0
Finland Reima Linnanvirta
79%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 3.2
Lithuania 70 Ventures
78%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 4.2
Finland Wave Ventures
78%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 4.8
Sweden GU Ventures
76%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Pharma, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 2.0
United States Ramesh Haridas
76%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 2.0
Spain Inveniam
76%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 2.0
Denmark Accelerace
76%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.9
Denmark Blazar Capital
76%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 2.2
Netherlands UNIIQ
76%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 2.2
Top